Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cost prostate psa service |
|
5. Cost Effectiveness of Screening with PSA : BC Cancer Agency Cost-effectiveness of prostate cancer screening has been estimated in a few The BC Cancer Agency is a part of the Provincial Health Services Authority . HBNS: Robot-Assisted Prostate Surgery Has Possible Benefits Release Date:August 29, 2005. Robot-Assisted Prostate Surgery Has Possible Benefits, Higher Costs. By Lisa Esposito, Editor Health Behavior News Service Using PSA Intelligently to Manage Prostate Cancer, Part 1 PSA is the tumor marker of choice to aid in the diagnosis of prostate cancer (PC), but may also reduce healthcare costs associated with PC screening. Prostate (PSA) hometesting, information, ordering (mainpage) MiraTes offers a free reminder service for helping you remind your annual Prostate (PSA) test. For subscription to this reminder service, please send an Prostate cancer gene 3 (Progensa PCA3) assay (Diagnosis of New costs: Savings: Potential reduction in Other: prostate biopsies and repeat PSA testing. References 1 Groskopf et al. APTIMA PCA3 Molecular Urine Test: Screening for Prostate Cancer: Recommendation and Rationale Prostate-specific antigen (PSA) best practice policy. Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs J. Clin. Screening for prostate cancer: recommendations and rationale. Prostate specific antigen (PSA) testing and digital rectal examination (DRE) can . Cost Work Group of the Third U.S. Preventive Services Task Force. First Hand: Marva Price, DrPH, RN, FAAN - DukeHealth.org The screening evaluation involves the digital rectal examination and a baseline prostate specific antigen (PSA) blood test. Subsequent annual digital rectal Prostate cancer awareness week. Education, service, and research screening centers to charge men for at-cost PSA pro- .. search, and service in prostate cancer detection and. treatment. References Changepoint to Help Cost-conscious Fortune 2000 Companies and PSA - Prostate-Specific Antigen PSA - Public Service Advertisement and established companies are looking to PSA to improve efficiency and contain costs. U.S. Preventive Services Task Force - February 15, 2003 - American PSA testing and DRE can effectively detect prostate cancer in its early . the cost-effectiveness of screening for prostate cancer is impossible to Serum prostate-specific antigen screening for prostate cancer We examine whether the use of PSA test in General Health Services, was performed rationally, and cost effectively. Methods: Phase 1: Collection of data on Prostate cancer screening deemed cost-effective in recent report OTA's report, Preventive Services under Medicare: Costs and Effectiveness that all men have access to prostate screening assessment (PSA) surveillance. Cost-Effectiveness of Percent Free PSA for Prostate Cancer The incremental cost-effectiveness ratio for free PSA + TRUS-Bx compared with TRUS-Bx US Preventive Services Task Force: Screening for prostate cancer: IngentaConnect Metastatic and PSA progression inflate costs in Beyond Print: enhancing your service · Access and authentication · Article purchasing Metastatic and PSA progression inflate costs in prostate cancer Kit Watch Serum PSA Mar 1994; 2-4 An asymptomatic patient with untreated prostate cancer with a serum PSA of 10 eg/L A PSA service should be available. Q: What cost savings are likely? Screening for Prostate Cancer: Recommendations and Rationale The U.S. Preventive Services Task Force (USPSTF) concludes that the PSA testing is more sensitive than DRE for the detection of prostate cancer. Prostate cancer services utilization pre- and post-PSA: a Prostate cancer services utilization pre- and post-PSA: a population-based analysis. Cost increases also reflect changing practice patterns and prices. |
| cost prostate psa service |
|
canine prostate cancer symptoms green laser prostate cancer cure food prostate anavar hair loss prostate |